The search for validated biomarkers in the face of biosystems complexity

16 April 2005 , By Professor Ian Humphery-Smith and Will Dracup , Spring 2005
Posted in Archive, Precision Medicine | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The search for validated biomarkers in the face of biosystems complexity By Professor Ian Humphery-Smith and Will Dracup As the pharmaceutical industry is all too well aware, the genomics and postgenomic sciences have delivered an excessive number of drug targets few of which have been well validated. Indeed, apart from a few rare exceptions, genomics [...]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!

Suggested Reading

Collaborative Research Leads To New Understanding Of Biomarkers
6 August 2020 , By Dr Max Ryadnov and Professor Jason Crain
Innovative glycan imaging methods drive cancer biomarker discovery
12 April 2020 , By Dr Richard Drake, Dr Anand Mehta and Dr Peggy Angel , Volume 21 Issue 2 - Spring 2020

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free